RAVELLI, COSETTA
 Distribuzione geografica
Continente #
NA - Nord America 4.636
EU - Europa 3.234
AS - Asia 2.662
SA - Sud America 440
Continente sconosciuto - Info sul continente non disponibili 174
AF - Africa 63
OC - Oceania 18
Totale 11.227
Nazione #
US - Stati Uniti d'America 4.510
PL - Polonia 1.224
SG - Singapore 901
CN - Cina 801
IT - Italia 654
BR - Brasile 352
HK - Hong Kong 283
UA - Ucraina 269
DE - Germania 256
VN - Vietnam 217
FI - Finlandia 178
GB - Regno Unito 147
FR - Francia 138
IN - India 99
BD - Bangladesh 80
TR - Turchia 78
RU - Federazione Russa 73
CA - Canada 65
IE - Irlanda 64
NL - Olanda 41
AR - Argentina 38
ID - Indonesia 38
BE - Belgio 35
ES - Italia 35
JP - Giappone 30
MX - Messico 29
ZA - Sudafrica 29
SE - Svezia 28
CZ - Repubblica Ceca 24
IQ - Iraq 21
AT - Austria 17
EC - Ecuador 17
PK - Pakistan 14
AE - Emirati Arabi Uniti 13
AU - Australia 11
MY - Malesia 10
SA - Arabia Saudita 9
VE - Venezuela 9
JM - Giamaica 8
NG - Nigeria 8
PH - Filippine 8
UZ - Uzbekistan 8
CH - Svizzera 7
CO - Colombia 7
EG - Egitto 7
GR - Grecia 7
KR - Corea 7
CL - Cile 6
EE - Estonia 6
HN - Honduras 6
KE - Kenya 6
NZ - Nuova Zelanda 6
TH - Thailandia 6
AL - Albania 5
IR - Iran 5
KZ - Kazakistan 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
GT - Guatemala 4
IL - Israele 4
MA - Marocco 4
OM - Oman 4
PE - Perù 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
PA - Panama 3
PY - Paraguay 3
RO - Romania 3
UY - Uruguay 3
BY - Bielorussia 2
CY - Cipro 2
EU - Europa 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LV - Lettonia 2
NO - Norvegia 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
DK - Danimarca 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NP - Nepal 1
Totale 11.048
Città #
Warsaw 1.218
Ashburn 504
Singapore 475
San Jose 318
Fairfield 310
Hong Kong 279
Brescia 265
Jacksonville 213
Woodbridge 192
Ann Arbor 190
Chandler 180
Beijing 166
Seattle 136
The Dalles 134
Houston 129
Wilmington 123
New York 122
Council Bluffs 118
Princeton 114
Los Angeles 112
Cambridge 111
Helsinki 103
Dearborn 100
Dallas 92
Milan 79
Munich 73
Dong Ket 63
Nanjing 63
Istanbul 62
Lauterbourg 60
Dublin 59
Ho Chi Minh City 55
Columbus 51
Santa Clara 44
Buffalo 39
Shanghai 39
São Paulo 38
San Francisco 35
Turku 35
Jakarta 33
Orem 33
Brussels 31
Hanoi 31
Shenyang 31
London 28
Chicago 27
Changsha 26
Nanchang 26
Moscow 25
Phoenix 25
Des Moines 24
Jinan 23
Madrid 23
San Diego 22
Atlanta 21
Denver 21
Guangzhou 21
Montreal 21
Rome 21
Tokyo 20
Hebei 19
Toronto 19
Chennai 18
Johannesburg 18
Nuremberg 18
Boston 17
Brooklyn 17
Amsterdam 16
Lappeenranta 16
Frankfurt am Main 15
Boardman 14
Olomouc 14
Redondo Beach 14
Stockholm 14
Tianjin 13
Haikou 12
Las Vegas 12
Mexico City 12
Hangzhou 11
Augusta 10
Brasília 10
Charlotte 10
Fara Gera d'Adda 10
Zhengzhou 10
Dhaka 9
Kunming 9
Lanzhou 9
Naples 9
Poplar 9
Washington 9
Hefei 8
Jiaxing 8
Manchester 8
Paris 8
Romola 8
Abuja 7
Baghdad 7
Belo Horizonte 7
Coimbatore 7
Curitiba 7
Totale 7.500
Nome #
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 319
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 308
Claudin3 is localized outside the tight junctions in human carcinomas 298
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 295
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 283
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 282
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 281
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 280
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 273
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 254
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 231
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 231
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 203
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 197
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 197
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 194
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 189
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 188
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 186
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 178
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 170
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 168
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 167
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 165
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 163
Insights on the receptor dynamics during the spreading of endothelial cells 161
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 160
Simulation of VEGF receptor recruitment on ECs membrane 148
Vascular disrupting activity of combretastatin analogues 148
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 144
A mechano-biological model of the coupling between cellular con- tractility and VEGFR2/VEGF interactions. 143
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 141
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 140
Role of VEGFs in metabolic disorders 139
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 135
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 132
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 126
Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types 126
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 125
In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation 123
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 121
Role of VEGFR2 co-receptors in the modulation of the pro-angiogenic activity of gremlin. 121
Heparan-sulfate proteoglycans mediate the angiogenic activity of the novel VEGFR2 agonist gremlin 116
Modeling cell motility and receptor dynamics 115
Role of gremlin-1 in the pathophysiology of the adipose tissues 111
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 110
Flk-1/KDR and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 109
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 109
VEGFR2 recruitment and activation by substratum-immobilized gremlin 107
Identification and characterization of pro-oncogenic low frequency VEGFR2 mutations 107
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 106
Fluorolabeling of the PPTase-Related Chemical Tags: Comparative Study of Different Membrane Receptors and Different Fluorophores in the Labeling Reactions 105
Mechanobiology of the relocation of proteins in advecting cells: in vitro experiments, multi-physics modeling, and simulations 104
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 103
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 102
VEGFR2 RECRUITMENT AND ACTIVATION BY SUBSTRATE-IMMOBILIZED DRM/GREMLIN 100
Alternative method to visualize receptor dynamics in cell membranes 99
FGF-trapping hampers cancer stem-like cells in uveal melanoma 98
Molecular insight on the altered membrane trafficking of TrkA kinase dead mutants 96
The D647N mutation of FGFR1 induces ligand-independent receptor activation 93
The contribution of obesogenic behavior on global warming 93
VEGFR2 recruitment and activation by substrate-immobilized VEGF 92
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity 90
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants 90
Deficiency of AP1 Complex Ap1g1 in Zebrafish Model Led to Perturbation of Neurodevelopment, Female and Male Fertility; New Insight to Understand Adaptinopathies 88
Irisin regulates thermogenesis and lipolysis in 3T3-L1 adipocytes 88
The Extracellular Matrix modulates mechanotransduction and metabolic alteration in EC leading to melanoma vascularization 87
Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics 87
Brain accumulation of lactosylceramide characterizes GALC deficiency in a zebrafish model of Krabbe disease 86
Cancer-associated VEGFR2R1032Q sustains receptor activation also by promoting ligand-independent hetero-dimerization with co-expressed wild-type VEGFR2 and translocation into lipid rafts 81
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 78
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 75
Two-Photon Microscopy for the Investigation of Morphological and Quantitative Changes in Skin Chrono- and Photo-Aging 73
Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1 71
The impact of adipokines on vascular networks in adipose tissue 48
A Glucosylated BODIPY Uses the GLUT Channel to Target Cancer Cells in In Vitro and In Vivo Models 40
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodeling 26
The Metastatic Capacity of Melanoma Reveals Alternative Pathways of Cancer Dissemination 11
Totale 11.227
Categoria #
all - tutte 47.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022501 0 72 9 10 23 42 33 38 41 77 35 121
2022/2023555 82 45 27 29 50 111 13 58 76 9 23 32
2023/2024769 44 33 70 65 56 104 28 63 127 47 19 113
2024/20251.740 46 13 30 266 172 118 153 85 210 112 322 213
2025/20263.541 338 364 241 484 376 243 567 140 216 329 177 66
2026/2027240 137 103 0 0 0 0 0 0 0 0 0 0
Totale 11.227